Avoid NuvaRing for Women at High Risk of Clotting

October 2014

Updates to labelling will bring questions about the risk of thrombosis with NuvaRing.

We know that combined hormonal contraceptives increase the risk of blood clots.

But now women are hearing that the risk may be higher with NuvaRing than with combined OCs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Hypertension Recommend Using Three "Core" Meds for Resistant Hypertension
Antithrombotics Encourage Aspirin Alone After a Year for Most Stent Patients
Infectious Diseases Recommend IM Ceftriaxone Plus Oral Azithromycin for Gonorrhea
Rheumatoid Arthritis Recommend Folic Acid for Rheumatoid Arthritis Patients on Methotrexate
Natural Health Products Watch for Adverse Effects When Combining Garcinia cambogia and Serotonergic Meds
Women's Health Avoid NuvaRing for Women at High Risk of Clotting
Women's Health Avoid Topical NSAIDs During Pregnancy
Respiratory & Allergy Save Xolair as a Last Resort for Chronic Hives
Substance Use Disorder Watch for Signs of Gabapentin Abuse
Biologics Don't Automatically Substitute Remsima or Inflectra for Remicade
Cardiology Consider Recommending a Beta-Blocker for Surgery in High-Risk Patients
Anxiety Suggest Pregabalin as an Alternative to a Benzodiazepine for Anxiety